Status:
COMPLETED
Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Requiring Sedation by Sevoflurane in ICU
Adult Patients
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Describe the Richmond Agitation Sedation Scale (RASS) values corresponding to the values of Minimum alveolar concentration of sevoflurane during sedation of patients in ICU
Detailed Description
Prospective clinical study in ICU with sedated ventilated patients with sevoflurane using the Mirus® system. Pharmacological study of the concentration-effect relationship by administration at increas...
Eligibility Criteria
Inclusion
- Requiring sedation by sevoflurane in ICU
- Adult patients
- Patients covered by french health care system
- Patients who have given their consent or his family
Exclusion
- Pregnant or lactating women
- Sevoflurane anaphylaxia
- Known or suspected risk of malignant hyperthermia
- Refusal Protocol
- Brain-damaged patients
- Hemodynamic conditions not compatible with the use of sevoflurane
- ARDS patients
- Minor patients
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02202720
Start Date
August 1 2014
End Date
November 1 2014
Last Update
November 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003